TickerFactsScreenerDevelopers

Immuneering Corp (IMRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$14.62M2021: -$30.85M2022: -$44.10M2023: -$48.97M2024: -$55.00M2025: -$45.34M-$45.34M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$45.34M+17.6%
2024-$55.00M-12.3%
2023-$48.97M-11.0%
2022-$44.10M-42.9%
2021-$30.85M-111.0%
2020-$14.62M—